Psychemedics Profit Margin

The latest profit margin for PMD is -9.45% as of December 2024. That compares with -18.8% in the prior-year period — up 49.7% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside Psychemedics's historical trend and sector peers before judging valuation or financial health.

Over the past year, PMD's profit margin moved from -18.8% to -9.45% — a 49.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Psychemedics's valuation or profitability profile.

Against Healthcare companies, PMD currently prints -9.45% for profit margin, while the sector average sits near 13.76%. That is roughly 168.7% below the sector mean. Large gaps often invite a closer look at Psychemedics's growth, margins, and balance sheet.

Profit Margin shows how effectively Psychemedics converts resources into returns. At -9.45%, PMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -18.8% in the prior-year period — up 49.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PMD's profit margin (-9.45%), review year-over-year change from -18.8%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.